News & Media
Based in Danvers, Massachusetts, USA, Abiomed, Inc., part of Johnson & Johnson MedTech, is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure.
First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella® as a Therapy for AMI Cardiogenic Shock
November 27, 2023
Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella® Supported HRPCI at TCT Symposium
October 23, 2023
Impella® Heart Pumps
Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.
Abiomed Breethe OXY-1 System™ is an easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator that provides an independent oxygen source designed to support mobility.
Patient Stories of Heart Recovery
Our patients are the motivation for all that we do, and we take great joy in celebrating every patient’s success story. Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.